165 related articles for article (PubMed ID: 30849255)
1. Predictors of early hemorrhage in acute promyelocytic leukemia.
Naymagon L; Moshier E; Tremblay D; Mascarenhas J
Leuk Lymphoma; 2019 Oct; 60(10):2394-2403. PubMed ID: 30849255
[TBL] [Abstract][Full Text] [Related]
2. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of fatal bleeding in acute promyelocytic leukemia.
Mantha S; Tallman MS; Devlin SM; Soff GA
Thromb Res; 2018 Apr; 164 Suppl 1():S98-S102. PubMed ID: 29703492
[TBL] [Abstract][Full Text] [Related]
4. Open issues on bleeding and thrombosis in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2010 Apr; 125 Suppl 2():S51-4. PubMed ID: 20434005
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
Testa U; Lo-Coco F
Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
[TBL] [Abstract][Full Text] [Related]
6. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
[TBL] [Abstract][Full Text] [Related]
7. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ
Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357
[TBL] [Abstract][Full Text] [Related]
8. Hemorrhage in acute promyelocytic leukemia: Can it be predicted and prevented?
Naymagon L; Mascarenhas J
Leuk Res; 2020 Jul; 94():106356. PubMed ID: 32445941
[TBL] [Abstract][Full Text] [Related]
9. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
10. International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia.
Mitrovic M; Suvajdzic N; Bogdanovic A; Kurtovic NK; Sretenovic A; Elezovic I; Tomin D
Med Oncol; 2013 Mar; 30(1):478. PubMed ID: 23371042
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Escudier SM; Kantarjian HM; Estey EH
Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
[TBL] [Abstract][Full Text] [Related]
13. Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia.
Song YH; Qiao C; Xiao LC; Zhang R; Lu H-
Med Sci Monit; 2018 May; 24():3249-3255. PubMed ID: 29771870
[TBL] [Abstract][Full Text] [Related]
14. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy.
Abla O; Ribeiro RC; Testi AM; Montesinos P; Creutzig U; Sung L; Di Giuseppe G; Stephens D; Feusner JH; Powell BL; Hasle H; Kaspers GJL; Dalla-Pozza L; Lassaletta A; Tallman MS; Locatelli F; Reinhardt D; Lo-Coco F; Hitzler J; Sanz MA
Ann Hematol; 2017 Sep; 96(9):1449-1456. PubMed ID: 28597167
[TBL] [Abstract][Full Text] [Related]
15. Acute promyelocytic leukemia: impact of hemorrhagic complications on response to induction chemotherapy and survival.
Humphries JE; Hess CE; Stewart FM
South Med J; 1990 Oct; 83(10):1157-61. PubMed ID: 2218655
[TBL] [Abstract][Full Text] [Related]
16. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
Shahmarvand N; Oak JS; Cascio MJ; Alcasid M; Goodman E; Medeiros BC; Arber DA; Zehnder JL; Ohgami RS
Int J Lab Hematol; 2017 Aug; 39(4):375-383. PubMed ID: 28422420
[TBL] [Abstract][Full Text] [Related]
17. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
Breccia M; Lo Coco F
Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Dally N; Hoffman R; Haddad N; Sarig G; Rowe JM; Brenner B
Thromb Res; 2005; 116(2):109-14. PubMed ID: 15907524
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated hemostasis in acute promyelocytic leukemia.
Hisada Y
Int J Hematol; 2024 May; 119(5):526-531. PubMed ID: 38341391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
